| Anna Crady, AUD | |
|
302 Merchants Walk, Suite 100, Tuscaloosa, AL 35406-2290 | |
| (205) 523-9300 | |
| (205) 523-9301 |
| Full Name | Anna Crady |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 8 Years |
| Location | 302 Merchants Walk, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073963484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 1165A (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alabama Ear, Nose And Throat Specialists, Llc | 7719104504 | 5 |
News Archive
Patients with chronic tendinosis of the Achilles tendon can experience a reduction in pain when injected with a small amount of a dextrose solution, according to a recent study conducted by researchers at St. Paul's Hospital in Vancouver, BC.
After running for quite some time amidst intense debates, the New South Wales Government has announced plans to make the medically-supervised drug injecting centre at Kings Cross a permanent fixture. This unit has been functioning since 2001 and was still looking for permanency. A latest review of this trial center showed that it has successfully managed more than 3,000 overdoses and helped 12,000 drug users.
Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
Research published today indicates that the risk of heart disease in adulthood is more strongly related to how quickly children gain weight between the ages of two and eleven than their actual body weight at any particular age. Scientists believe this is linked to differences in insulin processing in later life.
› Verified 2 days ago
| Provider Name | Alabama Ear, Nose & Throat Specialists, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023421468 PECOS PAC ID: 7719104504 Enrollment ID: O20140819002191 |
News Archive
Patients with chronic tendinosis of the Achilles tendon can experience a reduction in pain when injected with a small amount of a dextrose solution, according to a recent study conducted by researchers at St. Paul's Hospital in Vancouver, BC.
After running for quite some time amidst intense debates, the New South Wales Government has announced plans to make the medically-supervised drug injecting centre at Kings Cross a permanent fixture. This unit has been functioning since 2001 and was still looking for permanency. A latest review of this trial center showed that it has successfully managed more than 3,000 overdoses and helped 12,000 drug users.
Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
Research published today indicates that the risk of heart disease in adulthood is more strongly related to how quickly children gain weight between the ages of two and eleven than their actual body weight at any particular age. Scientists believe this is linked to differences in insulin processing in later life.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anna Crady, AUD 302 Merchants Walk, Suite 100, Tuscaloosa, AL 35406-2290 Ph: (205) 523-9300 | Anna Crady, AUD 302 Merchants Walk, Suite 100, Tuscaloosa, AL 35406-2290 Ph: (205) 523-9300 |
News Archive
Patients with chronic tendinosis of the Achilles tendon can experience a reduction in pain when injected with a small amount of a dextrose solution, according to a recent study conducted by researchers at St. Paul's Hospital in Vancouver, BC.
After running for quite some time amidst intense debates, the New South Wales Government has announced plans to make the medically-supervised drug injecting centre at Kings Cross a permanent fixture. This unit has been functioning since 2001 and was still looking for permanency. A latest review of this trial center showed that it has successfully managed more than 3,000 overdoses and helped 12,000 drug users.
Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
Research published today indicates that the risk of heart disease in adulthood is more strongly related to how quickly children gain weight between the ages of two and eleven than their actual body weight at any particular age. Scientists believe this is linked to differences in insulin processing in later life.
› Verified 2 days ago
Ms. Sandra M. Hindman, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2120 Loop Rd, Tuscaloosa, AL 35405 Phone: 205-556-9494 | |
Christina A Albea, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 700 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-348-7131 Fax: 205-348-1845 | |
Katherine Heslop, AUDIOLOGIST Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1224 Mcfarland Blvd Ne Ste A, Tuscaloosa, AL 35406 Phone: 205-333-3330 | |
Shelby T Davis, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 302 Merchants Walk Ste 100, Tuscaloosa, AL 35406 Phone: 205-523-9300 Fax: 205-523-9301 | |
Dr. Carment L Taylor, PH.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2308b 6th St, Tuscaloosa, AL 35401 Phone: 205-391-9876 Fax: 205-391-9893 | |
Ua Speech And Hearing Center Audiologist Medicare: Medicare Enrolled Practice Location: 700 Univ Blvd E, Room 145, Tuscaloosa, AL 35401 Phone: 205-348-7131 Fax: 205-348-1845 |